Filing Flows › Comparisons › RYTM vs URGN
Rhythm Pharmaceuticals vs UroGen Pharma: RYTM and URGN compared
Rhythm Pharmaceuticals is the larger company: $92.1M of revenue in its latest quarter (Q3 2026) against $89.0M for UroGen Pharma (Q3 2026). UroGen Pharma is growing faster (+224% against +80% a year earlier). UroGen Pharma is more profitable, with an operating margin of 9.4% against -42.6%.
Where the money goes: RYTM and URGN
Rhythm Pharmaceuticals (RYTM) · Q3 2026
Rhythm Pharmaceuticals, Q3 2026: revenue $92.1M (+80% year over year), operating margin -42.6%, net loss $41.4M, operating cash flow −$3.1M. The chart follows the revenue to costs, profit and cash.
UroGen Pharma (URGN) · Q3 2026
UroGen Pharma, Q3 2026: revenue $89.0M (+224% year over year), operating margin 9.4%, net loss $1.5M, operating cash flow −$15.2M. The chart follows the revenue to costs, profit and cash.
| Rhythm Pharmaceuticals (RYTM) | UroGen Pharma (URGN) | |
|---|---|---|
| Latest quarter | Q3 2026 | Q3 2026 |
| Revenue | $92.1M | $89.0M |
| Revenue growth, Y/Y | +80% | +224% |
| Operating margin | -42.6% | 9.4% |
| Net earnings | −$41.4M | −$1.5M |
| Net margin | -44.9% | -1.6% |
| Operating cash flow | −$3.1M | −$15.2M |
Where the revenue comes from
UroGen Pharma
- Zusduri: $68.0M (76%)
- Jelmyto: $21.0M (24%)
Questions
Which is bigger, Rhythm Pharmaceuticals or UroGen Pharma?
Rhythm Pharmaceuticals is the larger company: $92.1M of revenue in its latest quarter (Q3 2026) against $89.0M for UroGen Pharma (Q3 2026).
Is Rhythm Pharmaceuticals or UroGen Pharma growing faster?
UroGen Pharma is growing faster (+224% against +80% a year earlier).
Which is more profitable, Rhythm Pharmaceuticals or UroGen Pharma?
UroGen Pharma is more profitable, with an operating margin of 9.4% against -42.6%.
More: Rhythm Pharmaceuticals earnings · how Rhythm Pharmaceuticals makes money · UroGen Pharma earnings · how UroGen Pharma makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Nov 3, 2026; 10-Q filed Nov 4, 2026). Fiscal quarters can end on different dates. Not investment advice.